Treace Medical Concepts, Inc.
TMCI- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001630627
In the last 90 days, Treace Medical Concepts, Inc. insiders filed 1 open-market purchase and 0 sales; 116 institutions reported holding it in 13F filings for Q2 2026, worth $126.8M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Treace Medical Concepts, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 1 filing
- 1 insider, $246.7K in total
- Open-market sells
- 0 filings
- Insiders trading
- 1
- Net value
- +$246.7K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Treace Medical Concepts, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Treace John T. | Chief Executive Officer | 7,404,383 | Aug 24, 2026 | 8 |
| Scanlan Sean F. | Chief Innovation Officer | 679,863 | Aug 12, 2026 | 5 |
| Hair Mark | Chief Financial Officer | 914,900 | Aug 12, 2026 | 6 |
| Elder Scot Michael | Chief Legl & Comp Off, CorpSec | 778,683 | Aug 12, 2026 | 6 |
| Bakewell John K | Director | 204,056 | May 19, 2026 | 1 |
| Hamilton Lawrence W | Director | 74,056 | May 19, 2026 | 1 |
| Kiernan Jane E | Director | 93,949 | May 19, 2026 | 1 |
| Berry Lance A | Director | 74,593 | May 19, 2026 | 1 |
| Jain Deepti | Director | 100,243 | May 19, 2026 | 1 |
| Hanna Betsy | Director | 75,243 | May 19, 2026 | 1 |
| Guglielmino Guy | Chief Commercial Officer | 490,901 | Jan 23, 2026 | 2 |
| Berutti Aaron | SVP, Sales | 205,092 | Aug 12, 2025 | 0 |
| Mott Richard W | Director | 1,096,861 | May 21, 2025 | 0 |
| Treace James T | Director | 1,223,441 | Aug 19, 2024 | 0 |
| Bays F Barry | Other: Former Director | 0 | Jun 8, 2023 | 0 |
| Timbie Thomas E | Director | 1,149,069Indirect | Mar 17, 2023 | 0 |
| Owens Daniel E. | Other: Chief Human Resources Officer | 30,914 | Mar 17, 2023 | 0 |
| Treace John R | Director | 1,822,790Indirect | May 11, 2022 | 0 |
| Frias Jaime A. | Chief Legal Officer | 50,659 | Mar 10, 2022 | 0 |
| Lubben Terry W. | SVP, Operations | 5,850 | Mar 10, 2022 | 0 |
| Ferguson Joe W. | SVP, Research & Development | 419,756 | Oct 8, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 6, 2022 (view filing) | Jul 5 | 1 day | Owens Daniel E.Chief HR Officer | SSale | −1.00K | $15.00 | −$15.0K | −8.5%10.7K after | |
| Jun 21, 2022 (view filing) | Jun 16-17 | 5 days | Treace James TDirector | SSale | −50.0K | $13.67 | −$683.4K | −3.7%1.29M after | 2 lots |
| Jun 3, 2022 (view filing) | Jun 1 | 2 days | Owens Daniel E.Chief HR Officer | SSale | −1.00K | $16.67 | −$16.7K | −8.5%10.7K after | |
| May 27, 2022 (view filing) | May 25-26 | 2 days | Treace James TDirector | SSale | −50.0K | $15.52 | −$775.8K | −3.6%1.34M after | 2 lots |
| May 20, 2022 (view filing) | May 18 | 2 days | Hair MarkChief Financial Officer | PPurchase | +6.20K | $15.80 | +$98.0K | +28.2%28.1K after | |
| May 11, 2022 (view filing) | May 9 | 2 days | Owens Daniel E.Chief HR Officer | SSale | −1.00K | $15.96 | −$16.0K | −8.5%10.7K after | |
| May 11, 2022 (view filing) | May 9 | 2 days | Treace John RDirector | SSale | −75.0K | $14.01 | −$1.05M | −4.0%1.82M after | 4 lots |
| Mar 14, 2022 (view filing) | Mar 10 | 4 days | Treace James TDirector | SSale | −2 | $19.21 | −$38.42 | −100.0%0 after | |
| Mar 10, 2022 (view filing) | Mar 8 | 2 days | Lubben Terry W.SVP, Operations | PPurchase | +2.50K | $18.62 | +$46.5K | +74.6%5.85K after | |
| Mar 4, 2022 (view filing) | Mar 2 | 2 days | Scanlan Sean F.SVP, Marketing | SSale | −25.0K | $20.82 | −$520.5K | −100.0%0 after | |
| Feb 10, 2022 (view filing) | Feb 8-9 | 2 days | Scanlan Sean F.SVP, Marketing | SSale | −25.0K | $20.04 | −$501.0K | −100.0%0 after | 2 lots |
| Jan 20, 2022 (view filing) | Jan 18-19 | 2 days | Treace James TDirector | SSale | −75.0K | $19.26 | −$1.44M | −5.1%1.39M after | 3 lots |
| Jan 12, 2022 (view filing) | Jan 10-11 | 2 days | Scanlan Sean F.SVP, Marketing | SSale | −47.7K | $20.15 | −$961.3K | −100.0%0 after | 2 lots |
| Jan 5, 2022 (view filing) | Jan 3-5 | 2 days | Scanlan Sean F.SVP, Marketing | SSale | −2.30K | $20.02 | −$46.0K | −100.0%0 after | 3 lots |
| Dec 30, 2021 (view filing) | Dec 28-29 | 2 days | Treace John T.Chief Executive Officer | SSale | −22.8K | $16.99 | −$388.0K | −0.4%5.42M after | 2 lots |
| Dec 30, 2021 (view filing) | Dec 28 | 2 days | Treace James TDirector | SSale | −1.56K | $16.88 | −$26.4K | −99.9%2 after | |
| Dec 27, 2021 (view filing) | Dec 22-27 | 5 days | Treace John T.Chief Executive Officer | SSale | −81.7K | $16.72 | −$1.37M | −1.5%5.45M after | 3 lots |
| Dec 27, 2021 (view filing) | Dec 22-27 | 5 days | Treace James TDirector | SSale | −42.4K | $16.64 | −$706.3K | −96.4%1.56K after | 3 lots |
| Dec 22, 2021 (view filing) | Dec 20-21 | 2 days | Treace John T.Chief Executive Officer | SSale | −60.5K | $15.98 | −$966.7K | −1.1%5.53M after | 4 lots |
| Dec 22, 2021 (view filing) | Dec 20-21 | 2 days | Treace James TDirector | SSale | −31.0K | $15.92 | −$493.4K | −41.3%44.0K after | 4 lots |
| Dec 17, 2021 (view filing) | Dec 15 | 2 days | Treace James TDirector | SSale | −75.0K | $16.07 | −$1.20M | −6.6%1.06M after | 2 lots |
| Nov 24, 2021 (view filing) | Nov 22-24 | 2 days | Treace James TDirector | SSale | −50.0K | $17.93 | −$896.5K | −3.4%1.43M after | 5 lots |
| Nov 24, 2021 (view filing) | Nov 22-24 | 2 days | Treace John T.Chief Executive Officer | SSale | −165.0K | $17.86 | −$2.95M | −2.9%5.59M after | 6 lots |
| Nov 17, 2021 (view filing) | Nov 15-17 | 2 days | Treace James TDirector | SSale | −75.0K | $20.61 | −$1.55M | −3.4%2.13M after | 4 lots |
| Nov 12, 2021 (view filing) | Nov 10 | 2 days | Scanlan Sean F.SVP, Marketing | SSale | −25.0K | $21.54 | −$538.5K | −100.0%0 after | 2 lots |
| Oct 22, 2021 (view filing) | Oct 20-22 | 2 days | Treace John T.Chief Executive Officer | SSale | −165.0K | $21.54 | −$3.55M | −2.8%5.75M after | 10 lots |
| Oct 22, 2021 (view filing) | Oct 20 | 2 days | Timbie Thomas EDirector | SSale | −11.2K | $25.18 | −$281.3K | −0.5%2.25M after | |
| Oct 4, 2021 (view filing) | Oct 1 | 3 days | Jain DeeptiDirector | PPurchase | +17.8K | $0.00 | $0 | –17.8K after | Derivative |